共 50 条
- [34] Present and future of immunotherapy in Neuroendocrine Tumors REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2021, 22 (03): : 615 - 636
- [39] Sintilimab in Patients with Previously Treated Metastatic Neuroendocrine Neoplasms ONCOLOGIST, 2022, 27 (08): : E625 - E632
- [40] Immunotherapeutics at the spearhead: current status in targeting neuroendocrine neoplasms Endocrine, 2021, 73 : 232 - 239